- Burchell Lecture: Cardiac Amyloidosis: Transition from rare, underdiagnosed and untreatable to an increasingly and easily recognized and treatable disorder (Flier) (Slides) (Recording)
Mathew S. Maurer, MD
Professor of Medicine
Arnold and Arelene Goldstein Professor of Cardiology
Director, Cardiac Amyloidosis Program
Director, Clinical Cardiovascular Research Laboratory for the Elderly
Columbia University, New York, NY
Physician: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Allina Health and Minneapolis Heart Institute Foundation. Allina Health is accredited by the ACCME to provide continuing medical education for physicians. Allina Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse: This activity has been designed to meet the Minnesota Board of Nursing continuing education requirements for 1.2 hours of credit. However, the nurse is responsible for determining whether this activity meets the requirements for acceptable continuing education.
Planning Committee: Dr. JoEllyn Abraham, Dr. Alex Campbell, Dr. Kevin Harris, Rebecca Lindberg, Dr. Michael Miedema, Dr. Scott Sharkey, Eva Zewdie and Jolene Bell Makowesky have declared that they do not have any conflicts of interest associated with the planning of this activity. Dr. David Hurrell declares the following relationship – honoraria: Boston Scientific.